UCB BEST FOR PATIENT Trademark

Trademark Overview

On Friday, December 24, 2010, a trademark application was filed for UCB BEST FOR PATIENT with the United States Patent and Trademark Office. The USPTO has given the UCB BEST FOR PATIENT trademark a serial number of 79092595. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, December 24, 2020. This trademark is owned by UCB PHARMA S.A.. The UCB BEST FOR PATIENT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely, scientific analysis and testing in the fields of central nervous system diseases, and autoimmune and inflammatory diseases; scientific and medical research related to central nervous system diseases, and autoimmune and inflammatory diseases; design for others in the field of pharmaceuticals for central nervous system diseases, and autoimmune and inflammatory diseases; industrial analysis and research services in the field of pharmaceuticals, chemicals, biomedicines and bacteriologicals for central nervous system diseases, and autoimmune and inflammatory diseases; design and development of computers and software
ucb best for patient

General Information

Serial Number79092595
Word MarkUCB BEST FOR PATIENT
Filing DateFriday, December 24, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, December 24, 2020
Registration Number4054672
Registration DateTuesday, November 15, 2011
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 30, 2011

Trademark Statements

Indication of Colors claimedThe color(s) blue and black is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the color blue appearing in the wording "UCB", the rectangular background of the circle and the line dividing the circle; the color black appearing in the wording "BEST FOR PATIENT".
Goods and ServicesScientific and technological services, namely, scientific analysis and testing in the fields of central nervous system diseases, and autoimmune and inflammatory diseases; scientific and medical research related to central nervous system diseases, and autoimmune and inflammatory diseases; design for others in the field of pharmaceuticals for central nervous system diseases, and autoimmune and inflammatory diseases; industrial analysis and research services in the field of pharmaceuticals, chemicals, biomedicines and bacteriologicals for central nervous system diseases, and autoimmune and inflammatory diseases; design and development of computers and software
Pseudo MarkYOU SEE BEST FOR PATIENT

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 22, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUCB Biopharma SPRL
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE
Party NameUCB PHARMA S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE
Party NameUCB PHARMA S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameUCB PHARMA S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Sunday, November 7, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, November 7, 2021DEATH OF INTERNATIONAL REGISTRATION
Tuesday, November 10, 2020CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, August 14, 2020CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, April 23, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, May 3, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, March 6, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, March 6, 2019INVALIDATION PROCESSED
Friday, February 22, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 22, 2018CANCELLED SECTION 71
Tuesday, November 15, 2016COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, November 26, 2015CHANGE OF OWNER RECEIVED FROM IB
Friday, September 4, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 4, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 25, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, June 20, 2012FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, June 20, 2012FINAL DISPOSITION PROCESSED
Wednesday, February 15, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, January 9, 2012NOTIFICATION PROCESSED BY IB
Tuesday, November 15, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, August 30, 2011PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 10, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 10, 2011NOTICE OF PUBLICATION
Tuesday, July 26, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 25, 2011ASSIGNED TO LIE
Thursday, June 30, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 28, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 28, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 28, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 28, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 28, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, April 17, 2011REFUSAL PROCESSED BY IB
Wednesday, March 30, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 30, 2011REFUSAL PROCESSED BY MPU
Wednesday, March 30, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 29, 2011NON-FINAL ACTION WRITTEN
Wednesday, March 23, 2011ASSIGNED TO EXAMINER
Tuesday, February 22, 2011APPLICATION FILING RECEIPT MAILED
Friday, February 18, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 17, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

patient best diseases nervous autoimmune inflammatory central system scientific services design research